ascopubs.org

Phase 1/2a trial of intravenous BAL101553, a novel tumor checkpoint controller (TCC), in advanced solid tumors.

Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors. A ...
Yahoo Finance

Intravenous Infusion Pumps Market is projected to account for over US$ 13.2 Billion and expand at a CAGR of 5.2% through 2032, by according to Persistence Market Research

New York:, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The global Intravenous Infusion Pumps Market was valued at US$ 5.2 Bn in 2021 and is expected to reach US$ 13.2 Bn by 2032, finds Persistence Market ...
ascopubs.org

Phase I and Pharmacokinetic Study of Irinotecan Administered as a Low-Dose, Continuous Intravenous Infusion Over 14 Days in Patients With Malignant Solid Tumors

S100-Beta, Melanoma-Inhibiting Activity, and Lactate Dehydrogenase Discriminate Progressive From Nonprogressive American Joint Committee on Cancer Stage IV Melanoma PURPOSE: To evaluate the ...
Medscape

SHINE: Intense IV Glucose Control Does Not Improve Functional Stroke Outcomes

HONOLULU — Intense intravenous (IV) glucose control is no better than using standard subcutaneous "sliding scale" insulin for improving functional outcomes after an ischemic stroke — and may even ...